NanoViricides logo
NanoViricides NNVC
$ 1.15 -2.54%
report update icon

Quarterly report 2027-Q1
added 11-16-2026

NanoViricides Operating Cash Flow | NNVC

Annual Operating Cash Flow NanoViricides

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
-7.7 M -8.48 M -6.32 M -5.67 M -5.89 M -8.21 M -6.67 M -6.8 M -7.78 M -7.9 M -6.83 M - - -5.8 M -4.22 M -4.51 M -2.05 M - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.05 M -8.48 M -6.32 M

Quarterly Operating Cash Flow NanoViricides

2027-Q1 2026-Q4 2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-3.64 M -2.12 M -1.93 M -2.05 M -1.59 M -1.7 M -1.99 M -2.19 M -2.59 M -1.48 M -1.94 M -1.72 M -1.17 M -1.5 M -1.74 M -1.4 M -1.03 M - -1.03 M -2.43 M - - -3.15 M -2.11 M -724 K - -2.4 M -324 K -2.24 M - -1.43 M -2.16 M -962 K - -962 K -3.12 M -962 K - -1.56 M -2.96 M -1.56 M - -2.22 M - - - - - - - - - - - -1.32 M - -27.3 M -897 K -1.42 M -2.72 M -1.35 M - -676 K -1.9 M -676 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-324 K -27.3 M -2.33 M

Operating Cash Flow of other stocks in the Biotechnology industry

Issuer Operating Cash Flow Price % 24h Market Cap Country
Rigel Pharmaceuticals Rigel Pharmaceuticals
RIGL
75.7 M $ 40.05 -2.78 % $ 720 M usaUSA
Celsion Corporation Celsion Corporation
CLSN
-13.9 M - -6.63 % $ 13.9 M usaUSA
I-Mab I-Mab
IMAB
-1.3 B - - $ 866 M chinaChina
Tenax Therapeutics Tenax Therapeutics
TENX
-35.8 M $ 1.27 -8.27 % $ 49.8 M usaUSA
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
VRTX
3.63 B $ 514.68 -1.15 % $ 132 B usaUSA
Genfit SA Genfit SA
GNFT
15.5 M - 2.54 % $ 160 B franceFrance
Biophytis SA Biophytis SA
BPTS
-12.9 M - -13.47 % $ 169 M franceFrance
SELLAS Life Sciences Group SELLAS Life Sciences Group
SLS
-28.4 M $ 13.67 -8.01 % $ 1.49 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
102 M - - $ 867 M germanyGermany
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
-24.5 M - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
28.7 M - - $ 4.9 B britainBritain
Rezolute Rezolute
RZLT
-64.6 M $ 3.92 -6.69 % $ 407 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
-5.59 M - -18.52 % $ 27.3 M britainBritain
Tiziana Life Sciences PLC Tiziana Life Sciences PLC
TLSA
-1.53 M $ 0.63 -7.05 % $ 67.2 M britainBritain
MorphoSys AG MorphoSys AG
MOR
-296 M - 2.43 % $ 254 M germanyGermany
Affimed N.V. Affimed N.V.
AFMD
-110 M - -34.95 % $ 21.5 M germanyGermany
AnPac Bio-Medical Science Co., Ltd. AnPac Bio-Medical Science Co., Ltd.
ANPC
-55.1 M - -1.58 % $ 28.1 M chinaChina
Celyad Oncology SA Celyad Oncology SA
CYAD
-28 M - - $ 12.5 M belgiumBelgium
Seer Seer
SEER
-44.4 M $ 1.34 -3.25 % $ 74.5 M usaUSA
Gracell Biotechnologies Gracell Biotechnologies
GRCL
-483 M - - $ 3.37 B chinaChina
Summit Therapeutics Summit Therapeutics
SMMT
-323 M $ 9.94 -6.01 % $ 7.43 B britainBritain
Shattuck Labs Shattuck Labs
STTK
-39.9 M $ 4.49 -1.43 % $ 312 M usaUSA
Silence Therapeutics plc Silence Therapeutics plc
SLN
-39.4 M $ 19.81 0.08 % $ 2.81 B britainBritain
Soligenix Soligenix
SNGX
-10.3 M $ 0.22 -8.25 % $ 1.14 M usaUSA
Sanofi Sanofi
SNY
10.8 B $ 46.51 0.97 % $ 56.8 B franceFrance
Spruce Biosciences Spruce Biosciences
SPRB
-33.3 M $ 38.02 -6.11 % $ 29.1 M usaUSA
Spero Therapeutics Spero Therapeutics
SPRO
-12.6 M $ 0.74 -10.95 % $ 41.5 M usaUSA
Sarepta Therapeutics Sarepta Therapeutics
SRPT
-205 M $ 13.34 -5.86 % $ 1.34 B usaUSA
Savara Savara
SVRA
-101 M $ 4.28 -17.95 % $ 952 M usaUSA
Sutro Biopharma Sutro Biopharma
STRO
-177 M $ 8.6 -1.38 % $ 73.1 M usaUSA
Tarsus Pharmaceuticals Tarsus Pharmaceuticals
TARS
-12.5 M $ 72.94 -6.09 % $ 3.05 B usaUSA
Supernus Pharmaceuticals Supernus Pharmaceuticals
SUPN
47.3 M $ 36.28 1.88 % $ 2.05 B usaUSA
TG Therapeutics TG Therapeutics
TGTX
-24.8 M $ 63.39 -2.3 % $ 9.15 B usaUSA
Viridian Therapeutics Viridian Therapeutics
VRDN
-276 M $ 29.91 -4.87 % $ 3.05 B usaUSA
Trevi Therapeutics Trevi Therapeutics
TRVI
-42.1 M $ 13.35 -2.73 % $ 1.8 B usaUSA
vTv Therapeutics vTv Therapeutics
VTVT
-25.3 M $ 16.0 -2.2 % $ 64.2 M usaUSA
Xenon Pharmaceuticals Xenon Pharmaceuticals
XENE
-279 M $ 36.89 -1.78 % $ 2.92 B canadaCanada
Xeris Pharmaceuticals Xeris Pharmaceuticals
XERS
28.6 M $ 16.95 2.02 % $ 2.72 B usaUSA
X4 Pharmaceuticals X4 Pharmaceuticals
XFOR
-85.6 M $ 3.01 1.69 % $ 127 M usaUSA